Source-grounded facts extracted from Pharmagreen Biotech Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Pharmagreen Biotech Inc. engaged Turner, Stone & Company L.L.P. as its auditor.
“the Board of Directors of the Company approved the appointment of Turner, Stone & Company L.L.P. (“Turner Stone”) as the Company’s new independent registered public accounting firm, effective immediately”
Sadler, Gibb & Associates, LLC resigned as auditor of Pharmagreen Biotech Inc..
“Pharmagreen Biotech, Inc. (the “Company”) has accepted the resignation of Sadler, Gibb & Associates, LLC (“SGA”) as its independent registered public accounting firm, which resignation was submitted to the Company in a letter dated April 27, 2023”
Pharmagreen Biotech Inc. entered into Securities Purchase Agreement with JanBella Group, LLC. valued at $50,000.
“Pharmagreen Biotech, Inc., a (“NV”) corporation (the “Company”) and JanBella Group, LLC. (the “Investor”) have entered into a Securities Purchase Agreement dated as of November 2nd, 2022 (the “Agreement”) providing for the issuance of the Convertible Promissory Note in the principal amount of $50,000”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.